Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Nephrology | Family Medicine

Kidney Cancer Clinical Trials

A listing of Kidney Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 Last 

Arizona

Research Site
Scottsdale Arizona 85259

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Tucson Arizona 85724

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

Research Site
Scottsdale Arizona 85258

A clinical trial seeking patients for a research study for the treatment of Renal Cell Adenocarcinoma, Clear Cell Renal Carcinoma, Clear Cell Renal Cell Carcinoma or Renal Cell Carcinoma

Mayo Clinic Scottsdale
Scottsdale Arizona 85259-5499

A clinical trial to evaluate treatments using hypoxia-activated prodrug TH-302, sorafenib tosylate, protein analysis and laboratory biomarker analysis for patients with Kidney Cancer or Liver Cancer

Arkansas

Research Site
Little Rock Arkansas 72205

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

University of Arkansas for Medical Sciences
Little Rock Arkansas 72205
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

California

Research Site
La Jolla California 92093-0698

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Los Angeles California 90024

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Los Angeles California 90048

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
San Francisco California 94115

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Stanford California 94305-5334

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

UCSD Moores Cancer Center
La Jolla California 92093
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Samuel Oschin Cancer Center at Cedars-Sinai Medical Center
Los Angeles California 90048
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

David Geffen School of Medicine at UCLA
Los Angeles California 90024
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

California Pacific Medical Center Research Institute
San Francisco California 94115
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Colorado

Research Site
Aurora Colorado 80045

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Aurora Colorado 80045

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Colorado Springs Colorado 80909

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Denver Colorado 80211

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Parker Colorado 80134

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

University of Colorado Hospital
Aurora Colorado 80045
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

The Urology Center of Colorado
Denver Colorado 80211
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Advanced Urology, P.C.
Parker Colorado 80134
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Connecticut

Research Site
Hartford Connecticut 06102-5037

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

Hartford Hospital
Hartford Connecticut 06102
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Florida

Research Site
Miami Florida 33140

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Naples Florida 34102

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Orlando Florida 32806

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Tampa Florida 33612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

Specialists in Urology
Naples Florida 34102
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

MD Anderson - Orlando
Orlando Florida 32806
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

H. Lee Moffitt Cancer Center & Research Institute
Tampa Florida 33612
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Georgia

Research Site
Atlanta Georgia 30322

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Augusta Georgia 30912

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

Emory Univeristy Hospital
Atlanta Georgia 30322
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Taofeek Owonikoko, MD, PhD
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of BKM120 and Everolimus to evaluate Solid Tumors

Emory University Winship Cancer Institute
Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Lenalidomide and Everolimus to evaluate Solid Organ Malignancies

Georgia Regents University
Augusta Georgia 30912
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Idaho

Research Site
Boise Idaho 83706

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Meridian Idaho 83642

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

View More »

Saint Alphonsus Regional Medical Center
Boise Idaho 83706
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Idaho Urologic Institute
Meridian Idaho 83642
Updated

Patients are needed to participate in a clinical research study evaluating Standard Treatment and AGS-003 for the treatment of Advanced Renal Cell Carcinoma, Renal Cell Carcinoma or Metastatic Renal Cell Carcinoma

Illinois

Research Site
Chicago Illinois 60612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Chicago Illinois 60640

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Chicago Illinois 60612

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Sherman Health
Elgin Illinois 60123

SWOG S0931 Phase III Randomized Study of Everolimus Versus Placebo in Patients With Renal Cell Carcinoma Who Have Undergone Nephrectomy or Partial Nephrectomy

Research Site
Hines Illinois 60141

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Maywood Illinois 60153

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Skokie Illinois 60076

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

Research Site
Springfield Illinois 62702

An International Phase 3 Randomized Trial of Autologous Dendritic Cell Immunotherapy (AGS 003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (ADAPT)

First 1 2 3 4 5 6 Last